Anemia of inflammation develops in settings of chronic inflammatory, infectious, or neoplastic disease. In this highly prevalent form of anemia, inflammatory cytokines, including interleukin-6 (IL-6), stimulate hepatic expression of hepcidin, which negatively regulates iron bioavailability by inactivating ferroportin. 
Introduction
Anemia of inflammation (AI), also known as anemia of chronic disease (ACD), is the most prevalent form of anemia following iron-deficient anemia (IDA) 1, 2 . AI frequently occurs in patients with a broad array of infectious, autoimmune, or inflammatory disorders, as well as cancer and kidney disease, and can contribute to the morbidity associated with these conditions 3 . In contrast to IDA, AI is typically normochromic and normocytic with hemoglobin (Hb) levels greater than 8 g/dL; however, severe AI can lead to microcytosis 1, 2 . Patients with AI have diminished serum iron levels and transferrin saturations, whereas ferritin levels are normal or elevated 3 . Erythropoietin levels are typically elevated, but lower than those seen in patients with a similar degree of anemia attributable to iron deficiency. While a mild degree of anemia may be tolerated in patients who are otherwise healthy, anemia in patients with cardiovascular or pulmonary disease can impair systemic oxygen delivery, thereby worsening angina or dyspnea, or reducing exercise tolerance. Moreover, anemia is associated with worsened prognosis in cancer 4 , chronic kidney disease [5] [6] [7] , and congestive heart failure 5, 8, 9 .
When treatment of the underlying disease is incomplete or not feasible, blood transfusions, erythropoiesis-stimulating agents (ESAs), and iron supplementation have been used to increase Hb levels in AI. However, there are known risks associated with blood transfusion, and iron supplementation in AI requires intravenous (IV) administration. Moreover, aggressive treatment with ESAs can increase the cardiovascular events and mortality in patients with kidney disease 10 For personal use only. on September 24, 2017 . by guest www.bloodjournal.org From and may accelerate tumor progression in patients with cancer 11 . Thus, additional therapeutic options are needed for patients with AI.
A common feature of the disorders associated with AI is immune activation and production of inflammatory cytokines, such as interleukin 1β (IL-1β), IL-6, tumor necrosis factor-α (TNFα), and interferon-γ (IFNγ). IL-6 is especially potent in regulating the expression of the peptide hormone hepcidin, a central regulator of systemic iron balance [12] [13] [14] [15] . Hepcidin binds to and initiates degradation of ferroportin-1, the sole elemental iron exporter in vertebrates. Loss of ferroportin-1 activity prevents mobilization of iron to the bloodstream from intracellular stores in enterocytes and reticuloendothelial macrophages, leading to hypoferremia and anemia 16, 17 , even in the presence of sufficient dietary iron.
BMP signaling has been demonstrated to have important roles in the regulation of hepatic hepcidin expression and serum iron levels [18] [19] [20] [21] [22] . We previously used dorsomorphin, a small molecule inhibitor of BMP type I receptor kinases, to show that BMP signaling contributes to both iron-and IL-6-induced hepcidin expression and that BMP inhibition reduces hepcidin expression and increases serum iron levels in vivo 23 . These observations were complemented by the finding that the hepcidin promoter contains both BMP-responsive SMAD-binding and IL-6-responsive STAT3-binding elements, which act cooperatively to regulate hepcidin gene expression 24, 25 .
For personal use only. on September 24, 2017 . by guest www.bloodjournal.org From Based upon these concepts, we hypothesized that BMP signaling has a pivotal role in the pathogenesis of AI and sought to further define the relationship between BMP signaling and IL-6 in the regulation of hepcidin expression. We utilized cultured hepatoma cells, transgenic zebrafish, and mouse models, as well as a small molecule inhibitor of BMP type I receptors (LDN-193189) 26 , to elucidate the role of BMP signaling in modulating the effects of inflammatory mediators on the regulation of hepcidin expression and in the pathogenesis of anemia in an experimental AI model. We also examined the direct effect of BMP signaling on numbers and function of bone marrow (BM)-derived hematopoietic stem cells. Our studies in these complementary models support the concept that targeting BMP signaling might be effective for the treatment of AI.
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Materials and Methods:
Materials-Human recombinant IL-6 was obtained from R&D Systems (Minneapolis, MN). LDN-193189 (4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo [1,5- a]pyrimidin-3-yl)quinoline) was synthesized as a hydrochloride salt, as previously described 26 (with >98% purity as demonstrated by HPLC and 1 H-NMR); dissolved in sterile, endotoxin-free water at 1.5 mg/ml; and neutralized to pH 6.8.
Oil of turpentine was purchased from Sigma-Aldrich (St. Louis, MO Mastercycler ep Realplex (Eppendorf, Hamburg, Germany). The relative expression of target transcripts was normalized to levels of 18S rRNA for mouse and human RNA and to levels of ribosomal protein rpl13a RNA for zebrafish.
The sequences of primers used in these experiments are listed in Supplemental Table 1 .
Measurement of phosphorylated and total SMAD proteins-Cells or tissue were
harvested in RIPA buffer supplemented with protease and phosphatase inhibitors (Sigma). Extracts were fractionated using 10% Tris-SDS polyacrylamide gels, transferred to nitrocellulose membranes, and incubated with primary antibodies for total SMAD1 (Santa Cruz, Santa Cruz, CA) and phosphorylated forms of SMAD1/5/8 (Cell signaling, Danvers, MA), followed by HRP-linked anti-rabbit IgG (Cell Signaling, Danvers, MA). Bound antibodies were detected using ECL-Plus (GE Healthcare, Piscataway, NJ) and chemifluorescence with a Versdoc 4000MP imager (Bio-Rad, Hercules, CA).
IL-6 over-expression in zebrafish-Zebrafish over-expressing human IL-6 were generated using the GAL4-UAS system 27 . Briefly, the coding sequence of a hIL-6 cDNA was subcloned into a modified UAS-expression vector (pBH-UAS-Gtwy).
A transgenic zebrafish line (pBH-UAS-IL6) was established by microinjecting this construct into fertilized oocytes and out-crossing the founders to wild-type (WT) fish. To achieve cardiac-specific hIL-6 expression, the pBH-UAS-IL6 fish were mated with fish expressing the GAL4 protein under the control of cardiac myosin For personal use only. on September 24, 2017 . by guest www.bloodjournal.org From light chain 2 (cmlc2) promoter (pCH-Gtwy-G4VP16) to produce double transgenic fish (cmlc-Gal4::UAS-IL6 or "cmlc-IL-6"). Expression of the hIL-6 transgene in cmlc-IL-6 zebrafish hearts was confirmed by in situ hybridization and immunoblot analysis using a mouse monoclonal antibody directed against hIL-6 (MAB2061, R&D Systems). All experiments using zebrafish were approved by the Massachusetts General Hospital Subcommittee on Research Animal
Care.
Murine models of AI-All experiments were performed using 10 week-old C57BL/6 female mice (Jackson laboratories, Bar Harbor, ME) maintained on a standard iron-replete diet (Prolab Isopro® 3000 5P75; Labdiet, Richmond, IN). 
Results

BMP signaling is pivotal for the induction of hepcidin expression by IL-6 in
hepatoma cells-We examined the relationship between BMP signaling and IL-6-mediated hepcidin expression in HepG2 hepatoma cells. We found that IL-6 increased hepcidin mRNA levels within 60 min with peak levels achieved after 90 min (Supplemental Figure 1A Figure 1F ). Taken together, these findings suggest that the observed synergy between IL-6 and BMP signaling in regulating hepcidin was not attributable to the direct activation of the canonical BMP signaling pathway (i.e., SMAD-dependent) by IL-6.
BMP type I receptor inhibition reduces the ability of IL-6 to induce hepcidin
expression in zebrafish-Although a zebrafish orthologue for IL-6 has yet to be identified, the zebrafish genome contains an orthologue of the IL-6 receptor, suggesting that it might be feasible to test the ability of IL-6 to induce hepcidin For personal use only. on September 24, 2017. by guest www.bloodjournal.org From gene expression in zebrafish. To express IL-6 in zebrafish, double-transgenic zebrafish were generated in which the GAL4-UAS system and a cardiac myosin light chain (cmlc2) promoter were used to direct the expression of human IL-6 (hIL-6) in the heart ("cmlc-IL-6" transgenic fish). Expression of hIL-6 in the double-transgenic fish was confirmed by immunoblot and in situ hybridization (Figure 2A and Supplemental Figure 2A ). Transgenic expression of hIL-6 resulted in a four-fold increase in hepcidin mRNA levels in transgenic larvae (7 days post fertilization; Figure 2B ). Markedly elevated hepcidin mRNA levels were also found in the livers of adult cmlc-IL-6 transgenic fish (Supplemental Figure 3D) . Consistent with the notion that turpentine induces hepcidinemia and anemia in an IL-6-dependent fashion, we found that turpentine injection markedly increased IL-6 levels ( Figure 3E ). LDN-193189 
Discussion
In the present study, we reported that BMP signaling contributes to the induction of hepatic hepcidin expression by inflammatory signals in vitro and in vivo.
Studies in cultured hepatoma cells and experiments in zebrafish and mice
demonstrated that IL-6 does not directly activate BMP signaling (SMAD1/5/8 phosphorylation), but rather IL-6 activates hepcidin gene expression in a manner that is synergistic with BMP signaling. As has been previously described, we found that IL-6 and turpentine potently induce hepcidin expression in mice and that chronic turpentine administration leads to anemia 28, 31 . We demonstrated that the hypoferremia and hepcidin expression induced by turpentine administration, known to require IL-6 28, 32 20, 23, 33, 34 . In the current studies, we tested BMP6, known to be a critical BMP signaling ligand for the regulation of hepcidin in vivo 18, 35 . Our observations in hepatocyte-derived lines confirm the previously-described connection between BMP signaling-and IL-6-mediated regulation of hepcidin gene expression 24, 28, [36] [37] [38] . Neither IL-6 nor turpentine directly activated the BMP signaling pathway, as assessed by measuring phosphorylation of SMAD1/5/8. Rather, the synergy between BMP signaling and IL-6 in regulating hepcidin is likely mediated by the previously described interaction of their respective promoter elements upstream of the hepcidin gene 24, 36, 39, 40 . Our studies in zebrafish and mice corroborate the mechanistic link in vivo between inflammation-and BMP-mediated regulation of hepcidin gene expression.
Using the small molecule BMP inhibitor, dorsomorphin, we previously reported that hepatic BMP signaling is critical for basal regulation of hepcidin expression in zebrafish and mice and contributes to the induction of hepcidin expression in response to increased serum iron levels 23 . In the current study, we employed LDN-193189, a dorsomorphin derivative with greater potency and specificity than the parent compound 23, 26 , to inhibit hepcidin gene expression. LDN-193189 inhibited hepcidin expression in HepG2 cells in a dose-dependent manner with a similar potency to its inhibition of BMP4-induced activation of SMAD1/5/8 (IC 50~5 nM) 41 . To confirm that LDN-193189 exerted its effects by inhibiting BMP [42] [43] [44] . It is possible that IL-6 may interact with BMP signaling to regulate hepcidin expression via pathways that were not directly tested in our studies.
The turpentine-induced model of chronic inflammation has been used widely to assess the impact of inflammation on iron handling and erythropoiesis in mammals 13, 32 . This model recapitulates several features of the AI that have been observed in human subjects including hepcidinemia 13, 32, 45 , hypoferremia, 
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